Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5908)
All Articles published online
|
Sep 14, 2012 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu AG, Feng H, Wang PXZ, Han DP, Chen XH, Zheng MH. Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair. World J Gastroenterol 2012; 18(34): 4704-4713 [PMID: 23002339 DOI: 10.3748/wjg.v18.i34.4704] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i34/4704.htm |
| Number | Citing Articles |
| 1 |
Min Yang, Panpan Yao, Xuqiang Lang, Xue Li, Dawei Zhang. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial–mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma. Bioengineered 2021; 12(2): 12800 doi: 10.1080/21655979.2021.2001241
|
| 2 |
Yanjun Xu, Feng Li, Tan Wu, Yingqi Xu, Haixiu Yang, Qun Dong, Meiyu Zheng, Desi Shang, Chunlong Zhang, Yunpeng Zhang, Xia Li. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies. Oncotarget 2017; 8(9): 15453 doi: 10.18632/oncotarget.14973
|
| 3 |
Justin Barnes, Betty Pat, Yuan-Wen Chen, Pamela C. Powell, Wayne E. Bradley, Junying Zheng, Amrit Karki, Xiangqin Cui, Jason Guichard, Chih-Chang Wei, James Collawn, Louis J. Dell’Italia. Whole-genome profiling highlights the molecular complexity underlying eccentric cardiac hypertrophy. Therapeutic Advances in Cardiovascular Disease 2014; 8(3): 97 doi: 10.1177/1753944714527490
|
| 4 |
Sarah E. Huff, Jordan M. Winter, Chris G. Dealwis. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present. Biomolecules 2022; 12(6): 815 doi: 10.3390/biom12060815
|
| 5 |
Hao Feng, Jing-kun Zhao, Tobias S Schiergens, Pu-xiongzhi Wang, Bao-chi Ou, Rami Al-Sayegh, Ming-lun Li, Ai-guo Lu, Shuai Yin, Wolfgang E Thasler. Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation. British Journal of Cancer 2018; 118(3): 353 doi: 10.1038/bjc.2017.415
|
| 6 |
Y Aye, M Li, M J C Long, R S Weiss. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies. Oncogene 2015; 34(16): 2011 doi: 10.1038/onc.2014.155
|
| 7 |
Noor Pratap Singh, P. K. Vinod. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. Molecular Genetics and Genomics 2020; 295(3): 807 doi: 10.1007/s00438-020-01664-y
|
| 8 |
Gang Chen, Mingwei Yu, Jianqiao Cao, Huishan Zhao, Yuanping Dai, Yizi Cong, Guangdong Qiao. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Bioengineered 2021; 12(1): 5149 doi: 10.1080/21655979.2021.1960775
|
| 9 |
MATHIAS FÜLLER, MIRIAM KLEIN, EVA SCHMIDT, CHRISTIAN ROHDE, STEFANIE GÖLLNER, ISABEL SCHULZE, JIANG QIANLI, WOLFGANG E. BERDEL, BAYRAM EDEMIR, CARSTEN MÜLLER-TIDOW, PETRA TSCHANTER. 5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation. International Journal of Oncology 2015; 46(3): 1192 doi: 10.3892/ijo.2014.2792
|
| 10 |
Chi-Wei Chen, Yongming Li, Shuya Hu, Wei Zhou, Yunxiao Meng, Zongzhu Li, Yi Zhang, Jing Sun, Zhou Bo, Melvin L. DePamphilis, Yun Yen, Zhiyong Han, Wenge Zhu. DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2). Oncogene 2019; 38(13): 2364 doi: 10.1038/s41388-018-0584-6
|
| 11 |
Chunsheng Yang, Yan Liang, Ning Liu, Meili Sun. Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancer. Radiation Oncology 2023; 18(1) doi: 10.1186/s13014-023-02335-z
|
| 12 |
Zhenjiang Wang, Mingyi Guo, Xinbo Ai, Jianbin Cheng, Zaiwei Huang, Xiaobin Li, Yuping Chen. Identification of Potential Diagnostic and Prognostic Biomarkers for Colorectal Cancer Based on GEO and TCGA Databases. Frontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.602922
|
| 13 |
Tomas Ozdian, Dusan Holub, Zuzana Maceckova, Lakshman Varanasi, Gabriela Rylova, Jiri Rehulka, Jana Vaclavkova, Hanus Slavik, Pavel Moudry, Pawel Znojek, Jarmila Stankova, Juan Bautista de Sanctis, Marian Hajduch, Petr Dzubak. Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells. Journal of Proteomics 2017; 162: 73 doi: 10.1016/j.jprot.2017.05.005
|
| 14 |
Ehsan Pournoor, Zaynab Mousavian, Abbas Nowzari Dalini, Ali Masoudi-Nejad. Identification of Key Components in Colon Adenocarcinoma Using Transcriptome to Interactome Multilayer Framework. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59605-z
|
| 15 |
Chao Li, Jingfang Zheng, Si Chen, Bin Huang, Guosheng Li, Zichao Feng, Jiwei Wang, Shujun Xu. RRM2 promotes the progression of human glioblastoma. Journal of Cellular Physiology 2018; 233(10): 6759 doi: 10.1002/jcp.26529
|
| 16 |
Abhijeet R. Patil, Ming-Ying Leung, Sourav Roy. Identification of Hub Genes in Different Stages of Colorectal Cancer through an Integrated Bioinformatics Approach. International Journal of Environmental Research and Public Health 2021; 18(11): 5564 doi: 10.3390/ijerph18115564
|
| 17 |
Zijian Zhou, Qiang Song, Yuanyuan Yang, Lujia Wang, Zhong Wu. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer. Cancers 2022; 14(12): 2938 doi: 10.3390/cancers14122938
|
| 18 |
Sergio Corrales-Guerrero, Tiantian Cui, Veronica Castro-Aceituno, Linlin Yang, Sindhu Nair, Haihua Feng, Monica Venere, Stephanie Yoon, Todd DeWees, Changxian Shen, Terence M. Williams. Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1. Cancer Letters 2023; 570: 216308 doi: 10.1016/j.canlet.2023.216308
|
| 19 |
Prasanna Vidyasekar, Pavithra Shyamsunder, Rajpranap Arun, Rajalakshmi Santhakumar, Nand Kishore Kapadia, Ravi Kumar, Rama Shanker Verma, Zheng Li. Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks. PLOS ONE 2015; 10(8): e0135958 doi: 10.1371/journal.pone.0135958
|
| 20 |
Vei Mah, Mohammad Alavi, Diana C. Márquez-Garbán, Erin L. Maresh, Sara R. Kim, Steve Horvath, Lora Bagryanova, Sara Huerta-Yepez, David Chia, Richard Pietras, Lee Goodglick, Srikumar P Chellappan. Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status. PLOS ONE 2015; 10(5): e0127600 doi: 10.1371/journal.pone.0127600
|
| 21 |
Wen‐Hui Liang, Na Li, Zhi‐Qing Yuan, Xin‐Lai Qian, Zhi‐Hui Wang. DSCAM‐AS1 promotes tumor growth of breast cancer by reducing miR‐204‐5p and up‐regulating RRM2. Molecular Carcinogenesis 2019; 58(4): 461 doi: 10.1002/mc.22941
|
| 22 |
Sevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Panagiotis T. Diamantopoulos, Nefeli Giannakopoulou, Panagiota Katsiampoura, Christos Stafylidis, Georgios Dryllis, Marie-Christine Kyrtsonis, Maria Dimou, Panayiotis Panayiotidis, Nora-Athina Viniou. The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia. Clinical Hematology International 2023; 5(2-3): 92 doi: 10.1007/s44228-023-00033-x
|
| 23 |
Urbashi Basnet, Abhijeet R. Patil, Aditi Kulkarni, Sourav Roy. Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective. International Journal of Environmental Research and Public Health 2021; 18(11): 5525 doi: 10.3390/ijerph18115525
|
| 24 |
Qian Yang, Mingming Qi, Yongyu Chen, Shan Tian, Fei Liao, Weiguo Dong. ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell Growth. DNA and Cell Biology 2021; 40(7): 921 doi: 10.1089/dna.2020.6457
|
| 25 |
Zhipeng Zhu, Lulu Li, Jiuhua Xu, Weipeng Ye, Borong Chen, Junjie Zeng, Zhengjie Huang. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma. PeerJ 2020; 8: e9201 doi: 10.7717/peerj.9201
|
| 26 |
Lihua Zhang, Yonglong Yang, Lin Cheng, Yu Cheng, Hong-Hao Zhou, Zhi-Rong Tan. Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer Samples. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/3452739
|
| 27 |
Ye-han Liu, Min-min Shen, Yu-chen Wu, Kai-zhi Luo, Jian-kang Zhang, Zheng Wang, Zi-yi Chen, Jie Li, Si-yao Wu, Neng-ming Lin, Chong Zhang, Yang-ling Li. Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2. Phytomedicine 2024; 126: 155204 doi: 10.1016/j.phymed.2023.155204
|
| 28 |
Yi-Fan Chen, Frank Luh, Yuan-Soon Ho, Yun Yen. Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. Journal of Biomedical Science 2024; 31(1) doi: 10.1186/s12929-024-01055-0
|
| 29 |
Xiang Ding, Houyu Duan, Hesheng Luo. Identification of Core Gene Expression Signature and Key Pathways in Colorectal Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00045
|
| 30 |
Cheng-Yu Jin, Liang Du, A-Han Nuerlan, Xiao-Lei Wang, Yong-Wei Yang, Rui Guo. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma. Aging 2021; 13(3): 3518 doi: 10.18632/aging.202292
|
| 31 |
Xin Yin, Kan Jiang, Ziyang Zhou, Hao Yu, Danfang Yan, Xingkang He, Senxiang Yan, Giselle Cerchiaro. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/3878796
|
| 32 |
Chih-Wei Chen, Ning Tsao, Lin-Yi Huang, Yun Yen, Xiyong Liu, Christine Lehman, Yuh-Hwa Wang, Mei-Chun Tseng, Yu-Ju Chen, Yi-Chi Ho, Chian-Feng Chen, Zee-Fen Chang. The Impact of dUTPase on Ribonucleotide Reductase-Induced Genome Instability in Cancer Cells. Cell Reports 2016; 16(5): 1287 doi: 10.1016/j.celrep.2016.06.094
|
| 33 |
Md. Ariful Islam, Md. Bayazid Hossen, Md. Abu Horaira, Md. Alim Hossen, Md. Kaderi Kibria, Md. Selim Reza, Khanis Farhana Tuly, Md. Omar Faruqe, Firoz Kabir, Rashidul Alam Mahumud, Md. Nurul Haque Mollah. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer. Cancers 2023; 15(5): 1369 doi: 10.3390/cancers15051369
|
| 34 |
Gongshen Jin, Kangwei Wang, Yonghong Liu, Xianhu Liu, Xiaojing Zhang, Hao Zhang. Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(6): 687 doi: 10.2174/1871520620666200213102849
|
| 35 |
Xueting Hu, Jian Zhou, Yan Zhang, Yindi Zeng, Guitao Jie, Sheng Wang, Aixiang Yang, Menghui Zhang. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.942454
|
| 36 |
Miriam Yagüe-Capilla, Sean G. Rudd. Understanding the interplay between dNTP metabolism and genome stability in cancer. Disease Models & Mechanisms 2024; 17(8) doi: 10.1242/dmm.050775
|